Skip to main content
Clinical Trials/CTRI/2020/05/025311
CTRI/2020/05/025311
Not yet recruiting
未知

To Evaluate Dermatological Safety of InvestigationalProducts by 24 Hours Patch Test under CompleteOcclusion on Adult Healthy Human Subjects WithNormal Skin Type - SAFE/DAPT/2020-01

Dabur India Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dabur India Limited
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Healthy male and female subjects (1:1 ratio) in the age group of 18\-65 years (both age
  • inclusive).
  • 2\. Subjects with normal skin
  • 3\. Subjects with Fitzpatrick skin type III to V.
  • 4\. Female subjects with child bearing potential willing to undergo Urine Pregnancy Test.
  • 5\. Subjects free from excessive hair, cuts, wounds, irritation symptoms, abrasion or any
  • other skin condition which may interfere in the study results.
  • 6\. Subjects willing to give a voluntary written informed consent.
  • 7\. Subjects willing to maintain the patch test in position for 24 hours.
  • 8\. Subject having not participated in a similar investigation in the past two weeks.

Exclusion Criteria

  • 1\. Infection, allergy on the tested area.
  • 2\. Skin allergy antecedents or atopic subjects.
  • 3\. Subjects with known hypersensitivity to any of the study products or constituents.
  • 4\. Subjects with any significant skin pathology in the investigational area
  • 5\. Athletes and subjects with history of excessive sweating.
  • 6\. Cutaneous disease which may influence the study result.
  • 7\. Subjects using any topical or systemic treatment that could interfere with the study
  • treatments/assessments within the last 4 weeks prior to participation in the study and during the
  • 8\. Subjects on oral corticosteroid.
  • 9\. Subjects participating in any other cosmetic or therapeutic study.

Outcomes

Primary Outcomes

Not specified

Similar Trials